Skip to content

Commit 3655269

Browse files
WuyangFF95WuyangFF95
authored
Merge pull request #3 from WuyangFF95/WuyangFF95/bilingual-i18n-support
Add bilingual (中文/English) i18n support with language switcher
2 parents 4cea11b + 3cbd820 commit 3655269

19 files changed

+1464
-284
lines changed

‎docs/.vitepress/config.mjs‎

Lines changed: 64 additions & 17 deletions
Original file line numberDiff line numberDiff line change
@@ -1,31 +1,48 @@
11
export default {
2+
// Default locale (Chinese)
23
title: 'WU Yang',
34
description: 'Personal Website of WU Yang - Researcher / 研究员',
5+
6+
// i18n configuration
7+
locales: {
8+
root: {
9+
label: '中文',
10+
lang: 'zh-CN',
11+
title: 'WU Yang',
12+
description: 'Joe Poh Sheng YEONG 实验室 - 空间组学研究'
13+
},
14+
en: {
15+
label: 'English',
16+
lang: 'en-US',
17+
title: 'Joe Yeong Lab',
18+
description: 'Personal Website of WU Yang - Researcher / 研究员'
19+
}
20+
},
421
base: '/',
522

623
themeConfig: {
24+
// Chinese locale configuration (root/default)
725
nav: [
8-
{ text: 'Home / 首页', link: '/' },
9-
{ text: 'About / 关于', link: '/about' },
10-
{ text: 'Innovation / 创新', link: '/innovation' },
11-
{ text: 'Team / 团队', link: '/team' },
12-
{ text: 'Research / 研究', link: '/research' },
13-
{ text: 'News / 新闻', link: '/news' },
14-
{ text: 'Platforms / 平台', link: '/platforms' },
15-
{ text: 'Contact / 联系', link: '/contact' }
26+
{ text: '首页', link: '/' },
27+
{ text: '关于Yang', link: '/about-yang' },
28+
{ text: '创新', link: '/innovation' },
29+
{ text: '团队', link: '/team' },
30+
{ text: '研究', link: '/research' },
31+
{ text: '新闻', link: '/news' },
32+
{ text: '平台', link: '/platforms' },
33+
{ text: '联系', link: '/contact' }
1634
],
1735
sidebar: [
1836
{
19-
text: 'Navigation / 导航',
2037
items: [
21-
{ text: 'Home / 首页', link: '/' },
22-
{ text: 'About / 关于', link: '/about' },
23-
{ text: 'Innovation / 创新', link: '/innovation' },
24-
{ text: 'Team / 团队', link: '/team' },
25-
{ text: 'Research / 研究', link: '/research' },
26-
{ text: 'News / 新闻', link: '/news' },
27-
{ text: 'Platforms / 平台', link: '/platforms' },
28-
{ text: 'Contact / 联系', link: '/contact' }
38+
{ text: '首页', link: '/' },
39+
{ text: '关于Yang', link: '/about-yang' },
40+
{ text: '创新', link: '/innovation' },
41+
{ text: '团队', link: '/team' },
42+
{ text: '研究', link: '/research' },
43+
{ text: '新闻', link: '/news' },
44+
{ text: '平台', link: '/platforms' },
45+
{ text: '联系', link: '/contact' }
2946
]
3047
}
3148
],
@@ -37,6 +54,36 @@ export default {
3754
footer: {
3855
message: 'WU Yang - Personal Website / 武洋个人网站',
3956
copyright: 'Copyright © 2025 WU Yang / 武洋'
57+
},
58+
59+
// English locale configuration
60+
locales: {
61+
en: {
62+
nav: [
63+
{ text: 'Home', link: '/en/' },
64+
{ text: 'About Yang', link: '/en/about-yang' },
65+
{ text: 'Innovation', link: '/en/innovation' },
66+
{ text: 'Team', link: '/en/team' },
67+
{ text: 'Research', link: '/en/research' },
68+
{ text: 'News', link: '/en/news' },
69+
{ text: 'Platforms', link: '/en/platforms' },
70+
{ text: 'Contact', link: '/en/contact' }
71+
],
72+
sidebar: [
73+
{
74+
items: [
75+
{ text: 'Home', link: '/en/' },
76+
{ text: 'About Yang', link: '/en/about-yang' },
77+
{ text: 'Innovation', link: '/en/innovation' },
78+
{ text: 'Team', link: '/en/team' },
79+
{ text: 'Research', link: '/en/research' },
80+
{ text: 'News', link: '/en/news' },
81+
{ text: 'Platforms', link: '/en/platforms' },
82+
{ text: 'Contact', link: '/en/contact' }
83+
]
84+
}
85+
]
86+
}
4087
}
4188
}
4289
}

‎docs/about-yang.md‎

Lines changed: 43 additions & 0 deletions
Original file line numberDiff line numberDiff line change
@@ -0,0 +1,43 @@
1+
# 关于 Yang Wu
2+
3+
## WU Yang，博士
4+
5+
<div class="social-buttons">
6+
<a href="https://www.linkedin.com/in/yang-wu-59306283/" target="_blank" class="social-btn">
7+
<img src="/images/social/linkedin-icon.svg" alt="LinkedIn 简介" />
8+
</a>
9+
<a href="https://orcid.org/0000-0002-1837-8330" target="_blank" class="social-btn">
10+
<img src="/images/social/orcid-icon.svg" alt="ORCID 简介" />
11+
</a>
12+
</div>
13+
14+
### 研究科学家
15+
16+
WU Yang 博士是 Joe Yeong 实验室的研究科学家，专注于单细胞转录组学、空间转录组学和空间蛋白质基因组学研究。
17+
18+
### 研究兴趣
19+
20+
- 单细胞转录组学
21+
- 空间转录组学（Stereo-seq、10X Visium、10X Xenium）
22+
- 空间蛋白质组学
23+
- 荧光流式细胞仪数据分析
24+
- 肿瘤新抗原筛选
25+
26+
### 学术背景
27+
28+
- 博士，计算生物学（新加坡国立大学杜克-新国大医学院，2022年8月 ~ 2023年1月：博士后）
29+
- 博士，计算生物学（新加坡国立大学杜克-新国大医学院，2017年8月 ~ 2022年7月）
30+
- 理学学士（复旦大学生命科学学院，2013年9月 ~ 2017年6月）
31+
32+
### 当前职位
33+
34+
新加坡科技研究局（A*STAR）分子与细胞生物学研究院（IMCB）博士后、生物信息分析师
35+
36+
### 联系方式
37+
38+
- **电子邮件**：[wu_yang@a-star.edu.sg](mailto:wu_yang@a-star.edu.sg)
39+
- **ORCID**：[https://orcid.org/0000-0002-1837-8330](https://orcid.org/0000-0002-1837-8330)
40+
41+
---
42+
43+
_如需了解 Joe YEONG 教授的创新、知识产权和专业会员资格，请前往 [创新](/innovation) 页面。_

‎docs/contact.md‎

Lines changed: 0 additions & 1 deletion
Original file line numberDiff line numberDiff line change
@@ -78,5 +78,4 @@ Stay connected through online channels:
7878
- **ResearchGate**: [ResearchGate URL Placeholder]
7979
- **Google Scholar**: [Google Scholar URL Placeholder]
8080
- **ORCID**: [ORCID URL Placeholder]
81-
8281
---

‎docs/en/about-yang.md‎

Lines changed: 43 additions & 0 deletions
Original file line numberDiff line numberDiff line change
@@ -0,0 +1,43 @@
1+
# About Yang Wu
2+
3+
## WU Yang, PhD
4+
5+
<div class="social-buttons">
6+
<a href="https://www.linkedin.com/in/yang-wu-59306283/" target="_blank" class="social-btn">
7+
<img src="/images/social/linkedin-icon.svg" alt="LinkedIn Profile" />
8+
</a>
9+
<a href="https://orcid.org/0000-0002-1837-8330" target="_blank" class="social-btn">
10+
<img src="/images/social/orcid-icon.svg" alt="ORCID Profile" />
11+
</a>
12+
</div>
13+
14+
### Research Scientist
15+
16+
Dr. WU Yang is a Research Scientist at the Joe Yeong Lab, focusing on single-cell transcriptomics, spatial transcriptomics, and spatial proteogenomics.
17+
18+
### Research Interests
19+
20+
- Single-cell transcriptomics
21+
- Spatial transcriptomics (Stereo-seq, 10X Visium, 10X Xenium)
22+
- Spatial proteogenomics
23+
- Fluorescence flow cytometry data analysis
24+
- Tumor neoantigen screening
25+
26+
### Academic Background
27+
28+
- PhD, Computational Biology (Duke-NUS Medical School, National University of Singapore, Postdoc: Aug 2022 ~ Jan 2023)
29+
- PhD, Computational Biology (Duke-NUS Medical School, National University of Singapore, Aug 2017 ~ Jul 2022)
30+
- BSc, Life Sciences (Fudan University, Sep 2013 ~ Jun 2017)
31+
32+
### Current Position
33+
34+
Postdoctoral Fellow, Bioinformatics Analyst at Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore
35+
36+
### Contact
37+
38+
- **Email**: [wu_yang@a-star.edu.sg](mailto:wu_yang@a-star.edu.sg)
39+
- **ORCID**: [https://orcid.org/0000-0002-1837-8330](https://orcid.org/0000-0002-1837-8330)
40+
41+
---
42+
43+
_For Prof Joe YEONG's innovations, IPs and professional memberships, please go to [innovation](/innovation) page._

‎docs/en/contact.md‎

Lines changed: 64 additions & 0 deletions
Original file line numberDiff line numberDiff line change
@@ -0,0 +1,64 @@
1+
# Contact Us
2+
3+
## Laboratory Information
4+
5+
### Dr. Joe Poh Sheng YEONG
6+
**Principal Investigator & Laboratory Director**
7+
8+
### Office Location and Mailing Address
9+
Integrative Biology for Theranostics (JY Lab)
10+
#05-01 Proteos
11+
61 Biopolis Drive
12+
Singapore 138673
13+
14+
### Contact Details
15+
- **Email**: [yeongps@a-star.edu.sg](mailto:yeongps@a-star.edu.sg), [joe.yeong.p.s@sgh.com.sg](mailto:joe.yeong.p.s@sgh.com.sg)
16+
- **Phone**: +65 6586 9527
17+
18+
### Office Hours
19+
9am - 5pm SGT (GMT +8), Mon-Fri, except Singapore public holidays
20+
21+
---
22+
23+
## Research Inquiries
24+
25+
For research collaborations, questions about our work, or potential partnerships, please contact us via email. We welcome inquiries from:
26+
27+
- **Academic researchers** interested in collaboration
28+
- **Industry partners** seeking research partnerships
29+
- **Students** interested in joining our laboratory
30+
- **Media** requesting information about our research
31+
32+
### Response Time
33+
We typically respond to inquiries within 2-3 business days.
34+
35+
### Persons to contact when in travel
36+
37+
* Spatial-omics, multiplex IHC, IHC related: [Craig JOSEPH](mailto:craig_joseph@a-star.edu.sg)
38+
* Lab and admin matters: [LIM Xinru](mailto:limxr@a-star.edu.sg)
39+
* Manuscripts, grants, and general scientific docs matters: [Denise GOH](mailto:denise_goh@a-star.edu.sg)
40+
41+
---
42+
43+
## Directions
44+
45+
*[Google Maps widget will be embedded into the webpage]*
46+
47+
*[Directions to the laboratory location will be provided]*
48+
49+
### Public Transportation
50+
51+
Exit D (Biopolis), Buona Vista MRT station
52+
53+
---
54+
55+
## Social Media & Online Presence
56+
57+
Stay connected with our laboratory through our online channels:
58+
59+
- **Laboratory Website**: [Current website]
60+
- **Institutional Profile**: [A*STAR Profile](https://research.a-star.edu.sg/researcher/joe-yeong/)
61+
- **Professional Networks**: [LinkedIn](https://www.linkedin.com/in/joe-yeong/), [ResearchGate](https://www.researchgate.net/profile/Joe-Yeong-2)
62+
- **Academic Profiles**: [Google Scholar](https://scholar.google.com/citations?user=zSDQ4D8AAAAJ), [ORCID](https://orcid.org/0000-0002-6674-7153)
63+
64+
---

‎docs/en/index.md‎

Lines changed: 24 additions & 0 deletions
Original file line numberDiff line numberDiff line change
@@ -0,0 +1,24 @@
1+
# AI^3: AI + Immunology, Innovation, Intelligence
2+
3+
## Welcome to AI in Immunology Laboratory of Prof. Joe Poh Sheng YEONG
4+
5+
We focus on cutting-edge researches on AI in immunology, tumor pathology, spatial multi-omics to understand tumor theranostics (diagnostics + therapy).
6+
7+
### Research Focus
8+
9+
Our laboratory specializes in:
10+
11+
- Human experts and AI models in tumor pathology
12+
- Multi-omics and spatial multi-omics integrative data analysis
13+
- Biomarker discovery and validation
14+
- Translational research applications - AIDD, cancer vaccine and companion diagnostics assay development
15+
16+
### Latest News
17+
18+
Stay tuned for updates on our latest research findings, publications, and laboratory achievements.
19+
20+
---
21+
22+
*For more information about our research, team, and opportunities, please explore the navigation menu above.*
23+
24+
[Learn more about Yang Wu →](/en/about-yang)

‎docs/en/innovation.md‎

Lines changed: 54 additions & 0 deletions
Original file line numberDiff line numberDiff line change
@@ -0,0 +1,54 @@
1+
# Innovation
2+
3+
## Innovations & IPs
4+
5+
- Automated staining protocol for seven-colour immunofluorescence of human and animal tissue sections for diagnostic and prognostic use (TEC-18-96)
6+
- PD-L1 monoclonal antibody as a diagnostic tool to predict anti-PD-L1 and anti-PD-1 immunotherapy response in cancer (IMC/Z/12757)
7+
- IHC staining for CD38 predict anti-PD-1 immunotherapy response (TEC-18-92) and in house engineered antibody (2023-019)
8+
- IHC staining for CD39 predict PD-1/PD-L1 inhibitor immunotherapy response (IMC/Z/11149) and in-house engineered antibody (IMC/Z/13882)
9+
- PD-L2 monoclonal antibody as a diagnostic tool to predict anti-PD-L1 and anti-PD-1 immunotherapy response in cancer (2023-020)
10+
- Methodology for development of a direct multiplex immunohistochemistry prototype kit for CD39 and PD-L1 detection (2023-021)
11+
- 74 Antibodies Optimised for Immunohistochemistry (IHC) (IMC/Z/13562, licensed to ImmunoQs.)
12+
- Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple negative breast cancer: a translational assay compares to conventional IHC (DxD/Z/11878, licensed out to Lucence Diagnostic)
13+
- IHC-based clinical assay for EBC-129 ADC for cancer. (2021-01-11)
14+
- CD8+ T-cell prediction with AI in histological images. (Ref. 2024-021)
15+
- Method for Testing Multiple Tissue Samples on A Single Stereo-seq Spatial Transcriptomics Chip (ASTAR ref Z2024-280; RE 2024-016)
16+
- Blood-based Biomarkers for Lung Cancer (2024-009 - Z2024-158)
17+
- Integrated platform for neoantigen identification using patient derived tumor biopsy (2023-010 - IMC/Z/14352)
18+
- Albumin-based Multifunctional Nanocarriers for Cancer Vaccine Delivery (Z2024-108; PCT/SG2025/050559)
19+
- Whole slide blood smear assay on slides for high throughput protein and cell analysis (Z2024-755)
20+
- Whole slide smear imaging assay for high throughput cell culture analysis (Z2024-825)
21+
- PD-L1-expressing tumour cell prediction on haematoxylin and eosin-stained whole slide images (Z2024-656)
22+
- Low and High Molecular Weight Protein Enrichment (Z2024-690)
23+
- A computer-implemented method for cell-level detection a prediction of cancer biomarker associated features (ref: IP2024-030-01; PCT/SG2025/050432)
24+
- Antibody-drug conjugate target protein expression prediction on haematoxylin and eosin-stained whole slide images (Z2024-655, Licensed to ViewsML.)
25+
- Predictive Model for Mortality Risk Stratification Using Laboratory Biomarkers in Singaporeans (TD 2025-020, Licensed to Lucence Diagnostics)
26+
27+
---
28+
29+
## Professional Membership
30+
31+
- **Co-founder** World Immunotherapy Council Asian Chapter
32+
- **Co-Chair** World Immunotherapy Council 2019, 2023, 2025
33+
- **Committee Member** of Society of Immunotherapy for Cancer (SITC)
34+
- **Co-founder and Committee Member Clinical Day (CLINICCAI)** of International Conference on Medical Image Computing and Computer Assisted Intervention, **MICCAI**
35+
- **Executive Secretary** of Singapore Society of Oncology – Cancer immunotherapy consortium
36+
- **Education/Diagnostics Co-Lead**, **SingHealth Duke-NUS** Cell Therapy Centre
37+
- **Executive Committee Member**, Singapore Society of Pathology
38+
- **Founder**, Spatial JEDI Council
39+
- **Board & Committee Member**, **Asian Society of Digital Pathology** (ASDP)
40+
- **Board member**, Digital Pathology Special Interest Group, MICCAI
41+
- **Lead & Committee Member** of Society for Immunotherapy for Cancer (SITC)
42+
- **Committee Member**, Cancer Peak, Singapore General Hospital
43+
- **Membership** of United States and Canada Academy of Pathology (USCAP)
44+
- **Fellow** of British Royal College of Pathologist (RCPath)
45+
- **Membership** of Pathology Society of Great Britain and Ireland (SocPath)
46+
- **Membership** of Singaporean Society for Immunology (SgSi)
47+
- **Adjunct Membership** of International Academy of Pathology (IAP) - Singapore Division
48+
- **Membership** of European Society of Pathology
49+
- **NIH Alliance** of Digital Pathology
50+
- **Singapore Biodesign Alumni** (Winner of BEP program 2021)
51+
- **Member Board of Directors**, African & Asian Society of Digital Pathology (ASDP)
52+
- **Board Member**, Medical Image Computing and Computer Assisted Intervention (MICCAI) Society
53+
- **Board Member**, MICCAI Special Interest Group on Computational Pathology
54+
- **Committee member**, American Society of Clinical Oncology (ASCO)

‎docs/en/join-our-team.md‎

Lines changed: 11 additions & 0 deletions
Original file line numberDiff line numberDiff line change
@@ -0,0 +1,11 @@
1+
# Join Our Team
2+
3+
We are always looking for motivated researchers to join our laboratory. If you are interested in spatial omics research and computational biology, please contact us to discuss potential opportunities.
4+
5+
### Current Openings
6+
7+
*[Current position openings to be listed]*
8+
9+
### How to Apply
10+
11+
For inquiries about joining our laboratory, please send your CV and a brief cover letter describing your research interests and career goals.

0 commit comments

Comments
 (0)